• 1
    Lipmann M. Deposition and clearance of inhaled particles in the human nose. Ann Otol (St Louis) 1970;79:51925.
  • 2
    BarnesP, MygindN, editors. Budesonide. Clinical experience in asthma and rhinitis. Manchester : ADIS Press, 1988;144.
  • 3
    Mygind N, Vesterhauge S. Aerosol deposition in the nose. Rhinology 1978;16:7988.
  • 4
    Newman S, Morén F, Clarke SW. Deposition pattern of nasal sprays in man. Rhinology 1987;26:11120.
  • 5
    Mygind N, Lund V. Topical corticosleroid therapy of rhinitis: a review. Clin Immunother 1996;5:12236.
  • 6
    Soderberg-Warner ML. Nasal septal perforation associated with topical steroid therapy. J Pediatr 1984;105:8401.
  • 7
    Williams SJ. Side-effects of inhaled steroids. In: HargreaveFE, HoggJC, MaloJ-L, ToogoodJH, editors. Glucocorticoids and mechanisms of asthma. Amsterdam : Excerpta Medica, 1989;6885.
  • 8
    Toogood TH, Baskerville J, Jennings B, Lefcoe NM, Johansson SÅ. Use of spacers to facilitate inhaled corticosteroid treatment in asthma. Am Rev Respir Dis 1984;129:7239.
  • 9
    Morén F, Newman S. Aerosol particles and deposition in the airways. In: MygindN, PipkornU, DahlR, editors. Rhinitis and asthma: similarities and differences. Copenhagen : Munksgaard, 1990;25865.
  • 10
    Pedersen B, Dahl R, Mygind N. Bronchial response to oral and nasal inhalation of terbutaline and histamine. In: MygindN, PipkornU, DahlR, editors. Rhinitis and asthma: similarities and differences. Copenhagen : Munksgaard, 1990;26674.
  • 11
    Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy 1990;45:4516.
  • 12
    Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984;130:101418.
  • 13
    Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:1226.
  • 14
    Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:2506.
  • 15
    Watson WTA, Becker AB, Simons ER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97101.
  • 16
    Nielsen LP, Bjerke T, Christensen MB, et al. Intranasal fluticasone propionate inhibits the seasonal increase of local and systemic eosinophil markers in pollen allergic patients. Clin Exp Allergy 1998 (in press).
  • 17
    Wolthers OD, Pedersen S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal corticosteroids. Acta Paediatr Scand 1993;82:63540.
  • 18
    Wolthers OD, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 1991;303:1635.